CD34+ Hematopoietic Stem and Progenitor Cell (HSPC) Gene Modification and Overnight Recovery (Day 0)
6:33
Cell Harvest and Infusion Preparation (Day 1)
7:42
Liquid Culture Quality Control (Days 1-5)
9:19
Results: Representative HSPC Identification and Analysis
10:34
Conclusion
Transcription
To evaluate the efficiency and safety of promising and novel gene therapy approaches, the comprehensive testing of gene-modified cells in validated preclinical in vivo models is crucial. The conservation of relevant cell surface markers'cross-reac
Connectez-vous ou commencez votre essai gratuit pour accéder à ce contenu.
The goal of this protocol is to isolate nonhuman primate CD34+ cells from primed bone marrow, to gene-modify these cells with lentiviral vectors, and to prepare a product for infusion into the autologous host. The total protocol length is approximately 48 h.